Articles from FFF Enterprises.com

Submission deadline is February 17, 2026

TEMECULA, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- FFF Enterprises, Inc. — the nation’s most trusted specialty drug distributor and diversified healthcare company — today announced the exciting launch of RightNow Anywhere™ through RightNow Inventory™ (RNI), a subsidiary of FFF that develops intelligent inventory management devices and technology solutions.

TEMECULA, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Nufactor®, a specialty infusion company and subsidiary of FFF Enterprises, Inc., is pleased to announce the names of its 2025 Eric Dostie Memorial College Scholarship recipients. The annual scholarship program — now in its 31st year — grants 10 awards of $1,000 each to qualifying students affected by bleeding disorders who can best demonstrate scholastic achievement, community service, and financial need.

TEMECULA, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- FFF Enterprises, Inc., recognized as the nation’s most trusted specialty drug distributor and diversified healthcare company, is celebrating 37 years today of continued patient-centric care and solutions-driven innovation to answer unmet healthcare needs nationwide. 

TEMECULA, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- FFF Enterprises, Inc., recognized as the nation's most trusted specialty drug distributor and diversified healthcare company, is pleased to announce that we have upgraded our temperature-controlled packaging systems to include biodegradable foam coolers, enhancing the safe and secure distribution of a variety of pharmaceuticals and biologics.

TEMECULA, Calif, Dec. 10, 2024 (GLOBE NEWSWIRE) -- FFF Enterprises, Inc., recognized as the nation's most trusted specialty drug distributor and diversified healthcare company, announces the launch of ODRescue™ — opioid overdose mitigation tools designed to rapidly reverse an overdose emergency.

TEMECULA, Calif., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Nufactor®, a specialty infusion company and subsidiary of FFF Enterprises, Inc. announces its 2024 Eric Dostie Memorial College Scholarship recipients. The annual scholarship program grants 10 awards of $1,000 to qualifying students affected by hemophilia who can best demonstrate scholastic achievement, community service, and financial need.

TEMECULA, Calif., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Nufactor, Inc., a specialty infusion company and subsidiary of FFF Enterprises, Inc., is delighted to announce that it has received full certification as a Rare Disease Pharmacy Center of Excellence by the Utilization Review Accreditation Commission (URAC). This award is effective from September 1, 2024 to March 1, 2027.

TEMECULA, Calif., July 09, 2024 (GLOBE NEWSWIRE) -- FFF Enterprises, Inc., recognized as the nation's most trusted specialty drug distributor and diversified healthcare company, celebrates 13,151 consecutive days (and counting) of supplying healthcare professionals and patients with high-quality, counterfeit-free pharmaceuticals.

TEMECULA, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Nufactor®, a specialty infusion company and subsidiary of FFF Enterprises Inc. announces its 2023 scholarship recipients. The scholarship program annually grants 10 awards of $1,000 to qualifying students.

TEMECULA, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) -- FFF Enterprises Inc., recognized as the nation's most trusted specialty drug distributor and diversified healthcare company, has partnered with the industry’s top pharmaceutical manufacturers to carry Moderna and Novavax COVID-19 vaccines, ABRYSVO™ and AREXVY RSV vaccines, as well as RSV monoclonal antibody, Beyfortus™ — these products, along with our comprehensive portfolio of influenza vaccines, give healthcare providers the arsenal they need to combat the fast approaching 2023-2024 viral respiratory season.

TEMECULA, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Nufactor, Inc., a specialty pharmacy and subsidiary of FFF Enterprises Inc., announced that it has partnered with Verrica Pharmaceuticals to be the exclusive specialty pharmacy to dispense YCANTH™, the first FDA approved treatment of molluscum contagiosum in adult and pediatric patients 2 years of age and older.

TEMECULA, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) -- FFF Enterprises Inc., recognized as the nation's most trusted specialty drug distributor and diversified healthcare company, has partnered with Verrica Pharmaceuticals Inc. to distribute YCANTH™ (cantharidin) Topical Solution 0.7%, the first FDA approved treatment of molluscum contagiosum in adult and pediatric patients 2 years of age and older.

TEMECULA, Calif., July 07, 2023 (GLOBE NEWSWIRE) -- FFF Enterprises, Inc., recognized as the nation's most trusted specialty drug distributor and diversified healthcare company, celebrates 12,783 consecutive days (and counting) of supplying healthcare providers and patients with high-quality, counterfeit-free pharmaceuticals.

TEMECULA, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- Nufactor, Inc., a specialty infusion company and subsidiary of FFF Enterprises Inc., is pleased to announce that it has again been named a 2022 Pioneer in Performance Measurement by URAC. This marks the second consecutive year that Nufactor has received this prestigious award, having also earned it in 2021.

TEMECULA, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- FFF Enterprises Inc., the nation’s most trusted specialty drug distributor, today announced that it has entered an exclusive partnership with Sintetica® US—a subsidiary of international pharmaceutical company Sintetica S.A.—to provide Lidocaine Hydrochloride Injection, a short-acting amide-type local or regional anesthetic.

Temecula, Calif., March 08, 2023 (GLOBE NEWSWIRE) -- FFF Enterprises Inc., the nation’s most trusted specialty drug distributor, today announced that it has partnered with Amivas (US), LLC to stock FDA-approved Artesunate for Injection, the life-saving antimalarial treatment for severe malaria.

Submission deadline is March 1, 2023